Marion Jung

Title: Marion Jung - Innovator in Anti-Tumoral Therapy

Introduction

Marion Jung is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicine, particularly in the development of anti-tumoral therapy agents. His innovative approach focuses on enhancing drug targeting to combat cancer effectively.

Latest Patents

Marion Jung holds a patent for an anti-tumoral therapy agent that incorporates a contrast agent. This invention is centered around liposome-encapsulated cytostatic agents and their metabolites. The therapy aims to increase the concentration of these agents within tumors while minimizing toxic side effects on healthy organs. The inventive agent includes components such as PEG, immuno or immuno/PEG liposome-encapsulated cytostatic agents, degradable starch particles, and contrast agents like iodine, gadolinium, or magnetite. A preferred formulation features the cytostatic agent Carboplatinum, encapsulated in SUV-PEG, along with starch particle Spherex or Gelfoam and the contrast agent Gadolinium-DTPA. Marion Jung has 1 patent to his name.

Career Highlights

Throughout his career, Marion Jung has focused on innovative solutions in the pharmaceutical industry. His work has the potential to revolutionize cancer treatment by improving the efficacy of drug delivery systems.

Collaborations

Marion has collaborated with notable colleagues, including Regina Reszka and Gerd Berger. Their combined expertise contributes to the advancement of research in anti-tumoral therapies.

Conclusion

Marion Jung's contributions to anti-tumoral therapy represent a significant advancement in cancer treatment. His innovative approach and dedication to improving drug targeting systems highlight the importance of research in the pharmaceutical industry.